KALA KALA BIO, Inc.
$0.57▲ +1.69%
Healthcare
Other
After hours
$0.59▲ +3.07%
Sep 11, 7:30 PM ET
Volume 111.2K
Avg Volume (10D) 1.40M
Key Metrics & Fundamentals
Market Cap
$11.07M
P/E Ratio
–
Div Yield
–%
52W Range
0.49 - 1030.00
% vs 50 MA
-31.37%
% vs 200 MA
-95.59%
RSI-14
33.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.06
Free Cash Flow
-$1.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.58M
COGS
–
Operating Exp
$1.72M
Operating Income
-$1.72M
EBIT
-$1.72M
Pretax Income
-$1.58M
Net Income
-$1.58M
EPS (Diluted)
-21.32
Price & Volume History
Loading chart…
Recent News
Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests
InvestorsHub · Sep 3, 2026 1:47 PM
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
GlobeNewswire · Sep 3, 2026 12:30 PM
Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership
InvestorsHub · Sep 1, 2026 3:05 PM
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
GlobeNewswire · Sep 1, 2026 11:45 AM
KALA BIO: Q2 Earnings Snapshot
Associated Press · Aug 19, 2026 8:32 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See KALA's money flow as a full page
Social Sentiment
Avg -0.10 · 2 posts
DDNewsDiscussionKala Bio down 95% over 5 days - a pivot or reverse acquisition to become a “crypto treasury” company?
r/wallstreetbets · Oct 2, 2025
Significant stock drop, potential delisting, and discussion of a possible pivot point suggest a negative outlook.
very_negative
-0.80
DiscussionTradeWas it a mistake to buy these stocks?
r/investing · Jul 28, 2025
Post discusses losses in KALA, indicating a negative sentiment.
negative
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.